Pristiq Extended-Release is a Oral Tablet, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Wyeth Pharmaceuticals Llc, A Subsidiary Of Pfizer Inc.. The primary component is Desvenlafaxine Succinate.
Product ID | 0008-1222_0c40d9ea-730a-42d8-abd1-5a1da444dfb6 |
NDC | 0008-1222 |
Product Type | Human Prescription Drug |
Proprietary Name | Pristiq Extended-Release |
Generic Name | Desvenlafaxine Succinate |
Dosage Form | Tablet, Extended Release |
Route of Administration | ORAL |
Marketing Start Date | 2008-05-01 |
Marketing Category | NDA / NDA |
Application Number | NDA021992 |
Labeler Name | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. |
Substance Name | DESVENLAFAXINE SUCCINATE |
Active Ingredient Strength | 100 mg/1 |
Pharm Classes | Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2008-05-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA021992 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2014-03-18 |
Marketing End Date | 2015-03-25 |
Marketing Category | NDA |
Application Number | NDA021992 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2008-05-01 |
Marketing Category | NDA |
Application Number | NDA021992 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2008-05-01 |
Marketing Category | NDA |
Application Number | NDA021992 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2008-05-01 |
Marketing Category | NDA |
Application Number | NDA021992 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2008-05-01 |
Marketing Category | NDA |
Application Number | NDA021992 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2014-03-18 |
Marketing End Date | 2015-03-25 |
Ingredient | Strength |
---|---|
DESVENLAFAXINE SUCCINATE | 100 mg/1 |
SPL SET ID: | 0f43610c-f290-46ea-d186-4f998ed99fce |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
46708-540 | Desvenlafaxine | Desvenlafaxine Succinate |
46708-541 | Desvenlafaxine | Desvenlafaxine Succinate |
46708-542 | Desvenlafaxine | Desvenlafaxine Succinate |
50090-5274 | Desvenlafaxine | Desvenlafaxine Succinate |
50090-5293 | Desvenlafaxine | Desvenlafaxine Succinate |
51991-006 | Desvenlafaxine | Desvenlafaxine Succinate |
51991-311 | Desvenlafaxine | Desvenlafaxine Succinate |
51991-312 | Desvenlafaxine | Desvenlafaxine Succinate |
55700-577 | Desvenlafaxine | Desvenlafaxine Succinate |
50090-4069 | Desvenlafaxine Succinate | desvenlafaxine succinate |
59762-1210 | Desvenlafaxine Succinate | desvenlafaxine succinate |
0008-1210 | Pristiq | desvenlafaxine succinate |
0008-1211 | Pristiq | desvenlafaxine succinate |
0008-1222 | Pristiq | desvenlafaxine succinate |
35356-491 | Pristiq | desvenlafaxine succinate |
43063-262 | Pristiq | desvenlafaxine succinate |
55154-4230 | Pristiq | desvenlafaxine succinate |
55154-4235 | Pristiq | desvenlafaxine succinate |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
PRISTIQ 88308904 5828994 Live/Registered |
Wyeth LLC 2019-02-20 |
PRISTIQ 78541902 3477940 Live/Registered |
WYETH LLC 2005-01-04 |
PRISTIQ 77200228 3521683 Live/Registered |
WYETH LLC 2007-06-07 |